Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions

Circulation Research

Volumn 97, Issue 10, 2005, Pages 1001-1008

  Totary Jain, Hana ^a   Naveh Many, Tally ^b   Riahi, Yael ^a   Kaiser, Nurit ^b   Eckel, Jürgen ^c   Sasson, Shlomo ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Calreticulin; Glucose transporter 1; Hyperglycemia; mRNA turnover; Vascular endothelial cells; Vascular smooth muscle cells

Indexed keywords

CALRETICULIN; CIS ACTING ELEMENT; GLUCOSE; GLUCOSE TRANSPORTER 1; MESSENGER RNA; TRANS ACTING FACTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GLUCOSE TRANSPORT; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN STABILITY; PSAMMOMYS OBESUS; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

3' UNTRANSLATED REGIONS; ANIMALS; CALRETICULIN; CATTLE; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; GLUCOSE TRANSPORTER TYPE 1; HYPERGLYCEMIA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; RNA STABILITY; RNA, MESSENGER;

EID: 27944477788     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000189260.46084.e5     Document Type: Article

References (35)

1. Tenenbaum A, Motro M, Schwammenthal E, Fisman EZ. Macrovascular complications of metabolic syndrome: an early intervention is imperative. Int J Cardiol. 2004;97:167-172.
2. Giles TD, Sander GE. Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations. Cardiol Clin. 2004;22:553-568.
3. Brownlee M. Negative consequences of glycation. Metabolism. 2000;49(suppl 1):9-13.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
5. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes. 1985;34:621-627.
6. Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun. 1992;187:552-560.
7. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol. 2001;18:247-256.
8. Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, Sasson S. A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. Biochem J. 2002;362:413-422.
9. Alpert E, Altman H, Totary H, Gruzman A, Bamea D, Barash V, Sasson S. 4-Hydroxy tempol-induced impairment of mitochondrial function and augmentation of glucose transport in vascular endothelial and smooth muscle cells. Biochem Pharmacol. 2004;67:1985-1995.
10. Comford EM, Hyman S, Black KL, Comford ME, Vinters HV, Pardridge WM. High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium. J Neuropathol Exp Neurol. 1995;54:842-851.
11. Qi C, Pekala PH. The influence of mRNA stability on glucose transporter (GLUT1) gene expression. Biochem Biophys Res Commun. 1999;263:265-269.
12. Tsukamoto H, Boado RJ, Pardridge WM. Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3′-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA. J Clin Invest. 1996;97:2823-2832.
13. Boado RJ, Pardridge WM. Ten nucleotide cis element in the 3′-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Brain Res Mol Brain Res. 1998;59:109-113.
14. Dwyer KJ, Boado RJ, Pardridge WM. Cis-element/cytoplasmic protein interaction within the 3′-untranslated region of the GLUT1 glucose transporter mRNA. J Neurochem. 1996;66:449-458.
15. Boado RJ, Pardridge WM. Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis-acting regulatory element. J Neurochem. 2002;80:552-554.
16. Hamilton BJ, Nichols RC, Tsukamoto H, Boado RJ, Pardridge WM, Rigby WF. hnRNP A2 and hnRNP L bind the 3′UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun. 1999;261:646-651.
17. Jain RG, Andrews LG, McGowan KM, Pekala PH, Keene JD. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol. 1997;17:954-962.
18. Tsukamoto H, Hamada Y, Wu D, Boado RJ, Pardridge WM. GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues. Brain Res Mol Brain Res. 1998;58:170-177.
19. Gao GP, Engdahl RK, Wilson JM. A cell line for high-yield production of El-deleted adenovirus vectors without the emergence of replication-competent virus. Hum Gene Ther. 2000;11:213-219.
20. Sela-Brown A, Silver J, Brewer G, Naveh-Many T. Identification of AUF1 as a parathyroid hormone mRNA 3′-untranslated region-binding protein that determines parathyroid hormone mRNA stability. J Biol Chem. 2000;275:7424-7429.
21. Alpert E, Gruzman A, Riahi Y, Blejter R, Aharoni P, Weisinger G, Eckel J, Kaiser N, Sasson S. Delayed autoregulation of glucose transport in vascular endothelial cells. Diabetologia. 2005;48:752-755.
22. Coppolino MG, Dedhar S. Calreticulin. Int J Biochem Cell Biol. 1998;30:553-558.
23. Stephens JM, Carter BZ, Pekala PH, Malter JS. Tumor necrosis factor α-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes. Regulation by the adenosine-uridine binding factor. J Biol Chem. 1992;267:8336-8341.
24. Wertheimer E, Sasson S, Cerasi E, Ben-Neriah Y. The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. Proc Natl Acad Sci U S A. 1991;88:2525-2529.
25. 1 receptor mRNA by calreticulin. Circ Res. 2002;90:53-58.
26. Timchenko LT, Iakova P, Welm AL, Cai ZJ, Timchenko NA. Calreticulin interacts with C/EBPα and C/EBPβ mRNAs and represses translation of C/EBP proteins. Mol Cell Biol. 2002;22:7242-7257.
27. Chen MH, Frey TK. Mutagenic analysis of the 3′ cis-acting elements of the rubella virus genome. J Virol. 1999;73:3386-3403.
28. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature. 1999;400:378-382.
29. Muga SJ, Thuillier P, Pavone A, Rundhaug JE, Boeglin WE, Jisaka M, Brash AR, Fischer SM. 8S-Lipoxygenase products activate peroxisome proliferator-activated receptor α and induce differentiation in murine keratinocytes. Cell Growth Differ. 2000;11:447-454.
30. Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor γ and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res. 2001;61:497-503.
31. Johnson S, Michalak M, Opas M, Eggleton P. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol. 2001;11:122-129.
32. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature. 1994;367:476-480.
33. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M.Calreticulin: one protein, one gene, many functions. Biochem J. 1999;344:281-292.
34. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:e14-e22.
35. Kiri A, Goldspink G. RNA-protein interactions of the 3′ untranslated regions of myosin heavy chain transcripts. J Muscle Res Cell Motil. 2002;23:119-129.